Sherlock Biosciences

Sherlock Biosciences

Edit info

  • Founded: 2018
  • Location: Watertown, MA
  • Employee range: 11 - 50
  • Funding: $80M B Mar 2022; $7.5M grant May 2020; $31M A Mar 2019
  • Investors: Northpond Ventures, Baidu Ventures, Open Philanthropy Project


sherlock.bio

linkedin.com

job board


Business:

Molecular Diagnostics

About:

Sherlock Biosciences is using CRISPR technology to revolutionize diagnostics for DNA and RNA detection. Sherlock’s diagnostic tests are rapid, accurate, affordable and developed to be used at any time and location from saliva, urine, or blood. The company has two main diagnostic platforms: SHERLOCK and INSPECTR. SHERLOCK uses CRISPR technology and ‘smart amplicon detection’ to detect a specific nucleic acid signature in any organism or pathogen. A SARS-Cov-2 SHERLOCK kit has recently been FDA approved for clinical use. INSPECTR consists of dried synthetic gene networks that produce a reporter protein via cell-free transcription/translation upon target presence. Sherlock aims to decentralize testing anywhere to personalize healthcare and impact global health.

Jobs:

Post a job

News:

Sherlock Biosciences
web
Dec 31, 2024
Science/business updates
external-link
SHERLOCK-based one-step test provides rapid and sensitive Covid-19 detection - MIT News
googlenews
May 5, 2020
Science/business updates
external-link
BARDA Awards Revvity $9.2M, Partners With Sherlock Biosciences for COVID/Flu Home Tests
linkedin
Dec 19, 2024
Funding-related
external-link
Startup Led by Dhanda ’95 Developing COVID-19 Diagnostic Tests - Wesleyan University
googlenews
Mar 30, 2020
Science/business updates
external-link
OraSure Technologies Acquires Sherlock Biosciences - Yahoo Finance
googlenews
Dec 19, 2024
Funding-related
external-link
Sherlock is excited that the FDA recently approved an at-home test for syphilis that can provide initial results in just 15-minutes. Syphilis has been surging in recent years with the number of cases
linkedin
Oct 19, 2024
Science/business updates
external-link
Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself - Forbes
googlenews
May 14, 2019
Science/business updates
external-link
Sherlock and Tolo create CRISPR agreement - Drug Discovery News
googlenews
Dec 5, 2020
Science/business updates
external-link
Sherlock Biosciences Appoints Maurice Exner as Chief Scientific Officer - PR Newswire
googlenews
Apr 12, 2023
New hires
external-link
Sherlock Bio raises $80 million to develop CRISPR-based diagnostics - Reuters.com
googlenews
Mar 8, 2022
Funding-related
external-link
Sherlock Biosciences’ CEO: “It’s Better to Be Disruptive Than to Follow the Crowd”
crunchbase
Jul 27, 2021
Science/business updates
external-link
Sherlock Biosciences opens UK biomanufacturing facility at Swavesey for host of diagnostic devices
crunchbase
Aug 18, 2023
Science/business updates
external-link
September is Sexual Health Awareness Month. If you’re diagnosed with an #STI like #chlamydia or #gonorrhea the most important thing is getting treatment. You might be able to get treatment for your pa
linkedin
Sep 19, 2024
Science/business updates
external-link
Sherlock starts clinical trial for rapid OTC diagnostics for STIs - Clinical Trials Arena
googlenews
May 31, 2024
Science/business updates
external-link
CRISPR Takes on Diagnostics in the Wake of the Pandemic - CRISPR Medicine News
googlenews
Feb 14, 2022
Science/business updates
external-link
Sherlock starts clinical trial for rapid OTC diagnostics for STIs
crunchbase
May 29, 2024
Science/business updates
external-link
Sherlock Bio uncovers additional series A money for $49M ...
fiercebiotech.com
Dec 19, 2024
Funding-related
external-link
Sherlock Biosciences Is Cracking At-Home and Field Diagnostics - Genetic Engineering & Biotechnology News
googlenews
Jul 20, 2022
Science/business updates
external-link
Sherlock tackles mystery of STI underdiagnosis with at-home test - BioWorld Online
googlenews
Jun 12, 2024
Science/business updates
external-link
Sherlock Biosciences Receives Grant to Advance Development of Power-free Diagnostics - PR Newswire
googlenews
Nov 29, 2022
Funding-related
external-link
Dartmouth-Hitchcock starts study of new Covid-19 testing kit
crunchbase
Aug 13, 2020
Science/business updates
external-link
Sherlock Bio raises $80 million to apply COVID-testing tech to other diseases - The Boston Globe
googlenews
Mar 8, 2022
Funding-related
external-link
Gates Foundation backs 'instrument-free' molecular diagnostic tests through Sherlock, Mologic tie-up - Fierce Biotech
googlenews
Oct 30, 2019
Funding-related
external-link
FDA Authorizes First-Ever Crispr Application For COVID-19 Coronavirus Test - Forbes
googlenews
May 7, 2020
Science/business updates
external-link
Sherlock Biosciences names new CEO - Mass Device
googlenews
Jul 12, 2021
New hires
external-link
Sherlock obtains Cas12 CRISPR patent - Labiotech.eu
googlenews
Feb 27, 2023
Science/business updates
external-link
With Launch Of New CRISPR Company, Competition Extends To Diagnostics - Forbes
googlenews
Mar 21, 2019
Science/business updates
external-link
Sherlock Biosciences nabs Sense Biodetection to expand CRISPR diagnostic reach - Fierce Biotech
googlenews
Feb 1, 2023
Funding-related
external-link
Sherlock Biosciences Named PM360 Trailblazer 2022 Company of the Year for Medical Device/Diagnostics
web
Dec 31, 2024
Science/business updates
external-link
Sherlock Biosciences Starts Clinical Trial of Disposable Molecular STI Test vs. Central Lab Tests
crunchbase
May 30, 2024
Science/business updates
external-link
Sherlock Biosciences unearths $80M to bring CRISPR-based tests into the home - Fierce Biotech
googlenews
Mar 8, 2022
Funding-related
external-link
Other news to note for December 20, 2024
crunchbase
Dec 20, 2024
Science/business updates
external-link
Sherlock tackles mystery of STI underdiagnosis with at-home test
crunchbase
Jul 1, 2024
Science/business updates
external-link
Platforms
web
Dec 31, 2024
Science/business updates
external-link
Sherlock Biosciences Appoints Karen Davies as Chief Development Officer - PR Newswire
googlenews
Apr 7, 2022
New hires
external-link
Sherlock, Binx to develop first CRISPR-based POC test for COVID-19 - Drug Discovery & Development
googlenews
Jul 7, 2020
Science/business updates
external-link
Clinical Trial Update – CRISPR-Based Diagnostics for Sars-CoV-2 and Mycobacterium - CRISPR Medicine News
googlenews
Oct 28, 2020
Science/business updates
external-link
Sherlock Biosciences licenses Wyss Institute’s ambient nucleic acid amplification technology from Harvard to develop highly accurate, low-cost diagnostics for point-of-need
crunchbase
Oct 17, 2022
Science/business updates
external-link
Sherlock Biosciences Appoints Dr. Martin Madaus as Chief Operations Officer - Business Wire
googlenews
Sep 9, 2020
New hires
external-link
A COVID-19 diagnostic that uses CRISPR gets a nod from the FDA - Chemical & Engineering News
googlenews
May 7, 2020
Science/business updates
external-link
Weekly Refresh: Sonde Health Launched API, Akeneo’s New VP, and More
crunchbase
Nov 16, 2020
New hires
external-link
Sherlock Biosciences and binx health Announce Global Partnership to Develop First CRISPR-based Point-of-care Test for COVID-19 - Business Wire
googlenews
Jul 1, 2020
Science/business updates
external-link
Sherlock Biosciences and Tolo Biotech Expand Collaboration to Advance Development and Adoption of CRISPR-based Diagnostics - PR Newswire
googlenews
Nov 1, 2022
Science/business updates
external-link
Client Corner: Meet Syntis Bio Co-founder and CEO Rahul Dhanda - Mintz
googlenews
Nov 10, 2023
New hires
external-link
Sherlock Biosciences and Mologic Establish Strategic Partnership to Develop Instrument-free Molecular Diagnostic Tests - Business Wire
googlenews
Oct 30, 2019
Science/business updates
external-link
Sherlock at Apex of CRISPR-based Diagnostics after USPTO Grants Earliest Priority Patent - CRISPR Medicine News
googlenews
Feb 22, 2023
Science/business updates
external-link
Sherlock Biosciences and Integrated DNA Technologies (IDT) Announce Strategic Partnership for Manufacturing CRISPR SARS-CoV-2 Diagnostic and Research Products
crunchbase
Jun 8, 2020
Science/business updates
external-link
Forces Unite to Move Molecular Dx Out of the Gates
crunchbase
Oct 31, 2019
Science/business updates
external-link
Sherlock Biosciences CEO, Bryan Dechairo, on democratizing DNA and the power of curiosity
crunchbase
Mar 15, 2022
Science/business updates
external-link
Flagship Pioneering names Amy Lyons senior comms director - PR Week
googlenews
Jun 17, 2024
New hires
external-link
Sherlock, binx to develop point-of-care Covid-19 test using CRISPR technology
crunchbase
Jul 1, 2020
Science/business updates
external-link
Rahul Dhanda - World Economic Forum
googlenews
Nov 10, 2023
New hires
external-link
Sherlock Biosciences Unveils State-of-the-Art UK Biomanufacturing Facility
web
Dec 31, 2024
Science/business updates
external-link
Fear of stigma and rejection can lead to non-disclosure of STI status
linkedin
Sep 19, 2024
Science/business updates
external-link
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers - PR Newswire
googlenews
Feb 1, 2023
Science/business updates
external-link
Publications
web
Dec 31, 2024
Science/business updates
external-link
We're committed at Sherlock Biosciences to breaking down the stigma that surrounds sexual health. Health is health. Start a conversation today.#sexualhealthmonth #talktesttreat
linkedin
Oct 19, 2024
Science/business updates
external-link
Sherlock Biosciences Raises $80 Million in Series B Financing to Democratize At-Home Diagnostic Testing
crunchbase
Mar 8, 2022
Funding-related
external-link
Sherlock Biosciences’ CEO: “It’s Better to Be Disruptive Than to Follow the Crowd” - BioSpace
googlenews
Jul 26, 2021
Science/business updates
external-link
OraSure Expands Into $1.5B Molecular Testing Market with Sherlock Biosciences Acquisition - StockTitan
googlenews
Dec 19, 2024
Science/business updates
external-link
Sherlock Biosciences licenses Wyss Institute’s ambient nucleic acid amplification technology from Harvard to develop highly accurate, low-cost diagnostics for point-of-need
web
Dec 31, 2024
Science/business updates
external-link
How Biotech Can Succeed At Hybrid Work - Forbes
googlenews
Aug 20, 2023
Science/business updates
external-link
Sherlock Biosciences on LinkedIn: #cervicalcancerprevention #healthcareinnovation #sherlockbiosciences…
crunchbase
Feb 1, 2024
Science/business updates
external-link
CRISPR Comes To COVID: A Pandemic Pivot And The Push For A Simple Coronavirus Test - WBUR News
googlenews
Jul 10, 2020
Science/business updates
external-link
The 221b Foundation and LogicInk Announce License Agreement to Utilize Sherlock Biosciences’ CRISPR Technology to Develop Instrument-free Diagnostic for COVID-19
crunchbase
May 6, 2021
Science/business updates
external-link
OraSure Technologies Acquires Sherlock Biosciences - GlobeNewswire
googlenews
Dec 19, 2024
Science/business updates
external-link
Sherlock Biosciences Receives Grant to Advance Development of Power-free Diagnostics
web
Dec 31, 2024
Funding-related
external-link
Amy Lyons joins startup Sherlock Biosciences to lead comms - PR Week
googlenews
Apr 20, 2020
New hires
external-link
Sherlock Biosciences Appoints Karen Davies as Chief Development Officer
crunchbase
Apr 7, 2022
New hires
external-link
Sherlock Biosciences Raises $80 Million in Series B Financing to Democratize At-Home Diagnostic Testing - PR Newswire
googlenews
Mar 8, 2022
Funding-related
external-link
Sherlock Biosciences Licenses US Dx Rights to CRISPR-Cas12 From Tolo Biotech
crunchbase
Dec 4, 2020
Science/business updates
external-link
Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics - Genetic Engineering & Biotechnology News
googlenews
Feb 1, 2023
Science/business updates
external-link
Elementary Claim: Sherlock Gains Patent Rights for Cas12 in Diagnostics - Genetic Engineering & Biotechnology News
googlenews
Feb 22, 2023
Science/business updates
external-link
September is Gynecological Cancer Awareness Month! The five main types are cervical, ovarian, uterine, vaginal, and vulvar cancer. Early diagnosis increases the chances of survival. #StopHPVCancer #c
linkedin
Sep 19, 2024
Science/business updates
external-link
Biomedical Advanced Research and Development Authority (BARDA) on LinkedIn: We are partnering with Sherlock Biosciences to develop the Sherlock...
linkedin
Nov 19, 2024
Funding-related
external-link
CRISPR diagnostic maker Sherlock Biosciences says the ...
fiercebiotech.com
Dec 19, 2024
Science/business updates
external-link
www.sherlock.bio
web
Dec 31, 2024
Science/business updates
external-link
Sherlock Biosciences Receives Grant to Advance Development of Power-free Diagnostics
crunchbase
Nov 29, 2022
Funding-related
external-link
Sherlock's quick, CRISPR-based coronavirus test gets emergency nod
crunchbase
May 7, 2020
Science/business updates
external-link
Sherlock Biosciences nabs Sense Biodetection to expand ...
fiercebiotech.com
Dec 19, 2024
Funding-related
external-link
The World Health Association (WHO) recently declared a global health emergency amid rising cases of mpox. While there is no immediate threat in the US, the CDC is recommending vaccinations for higher
linkedin
Oct 19, 2024
Science/business updates
external-link
First CRISPR test for the coronavirus approved in the United States - Nature.com
googlenews
May 8, 2020
Science/business updates
external-link
The world’s first FDA-authorized CRISPR application. Interview: Rahul Dhanda, CEO Sherlock Biosciences. - CRISPR Medicine News
googlenews
May 21, 2020
Science/business updates
external-link
Sherlock Biosciences solves C-suite mystery, tapping ...
fiercebiotech.com
Dec 19, 2024
New hires
external-link
Sherlock Biosciences licenses Wyss technology to create affordable molecular diagnostics - Harvard Office of Technology Development
googlenews
Mar 21, 2019
Science/business updates
external-link
Sherlock Biosciences Appoints Julie Garlikov as Chief Commercial Officer - PR Newswire
googlenews
Jul 14, 2022
New hires
external-link
OraSure Technologies Acquires Sherlock Biosciences for Growth - TipRanks
googlenews
Dec 19, 2024
Funding-related
external-link
Sherlock Biosciences and Tolo Biotech Expand Collaboration to Advance Development and Adoption of CRISPR-based Diagnostics
crunchbase
Nov 1, 2022
Science/business updates
external-link
Sherlock Biosciences Appoints Julie Garlikov as Chief Commercial Officer
crunchbase
Jul 14, 2022
New hires
external-link
Make sure you put getting the HPV vaccine on your child’s back-to-school list! ✏️📚💉 What’s on your back-to-school list? #StopHPVCancer #backtoschool #hpv #hpvvaccine #schoolsupplies
linkedin
Sep 19, 2024
Science/business updates
external-link
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers
crunchbase
Feb 1, 2023
Science/business updates
external-link
Sherlock Biosciences unearths $80M to bring CRISPR-based tests into the home
crunchbase
Mar 8, 2022
Funding-related
external-link
Academic institutions grant commercial license for CRISPR-based SHERLOCK diagnostic technology in developed world - MIT News
googlenews
Mar 21, 2019
Science/business updates
external-link
Doudna's Intellia, Zhang's Aera the latest gene editing biotechs to lay off staff - Fierce Biotech
googlenews
Jan 4, 2024
Science/business updates
external-link
Abudayyeh co-founds engineering biology company - Harvard School of Engineering and Applied Sciences
googlenews
Mar 27, 2019
New hires
external-link
Sherlock Bio, Cepheid pair up to develop CRISPR diagnostics for coronavirus and more
crunchbase
Feb 28, 2020
Science/business updates
external-link
Sherlock Biosciences Receives FDA Emergency Use Authorization for CRISPR SARS-CoV-2 Rapid Diagnostic - Business Wire
googlenews
May 7, 2020
Science/business updates
external-link
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers
web
Dec 31, 2024
Science/business updates
external-link
Sherlock Biosciences solves C-suite mystery, tapping Myriad Genetics' Dechairo as CEO
crunchbase
Jul 12, 2021
New hires
external-link
Sherlock Biosciences Starts Clinical Trial of Disposable Molecular STI Test vs. Central Lab Tests - Business Wire
googlenews
May 30, 2024
Science/business updates
external-link


© 2025 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com